
Sartelbeta Plus 12.5mg/25mg/40mg Tablet ER
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Chlorthalidone (12.5mg) + Metoprolol Succinate (25mg) + Telmisartan (40mg)
Overview Sartelbeta Plus 12.5mg/25mg/40mg Tablet ER
Extended-release Sartelbeta Plus tablets (12.5mg/25mg/40mg) are a combined medication indicated for managing hypertension. This treatment lowers blood pressure by promoting vasodilation and improving cardiac output. It also facilitates diuresis, eliminating excess fluid and electrolytes. Sartelbeta Plus may be administered with or without food, but consistent timing optimizes efficacy. Increased urination is a common effect; therefore, daytime administration or at least four hours before sleep is recommended. Dosage and frequency are determined by your physician based on individual needs and should be adhered to as prescribed. Treatment duration is dictated by your doctor. Typical mild adverse effects include nausea, diarrhea, dyspepsia, headache, and lightheadedness. Regular monitoring of renal function and electrolyte levels is crucial. Optimal results are achieved when coupled with lifestyle modifications such as balanced nutrition, physical activity, and smoking abstinence. Increased fluid intake helps mitigate potential dryness of the mouth and thirst. Prior to commencing treatment, inform your physician of any pregnancy, circulatory disorders, or hepatic/renal impairments, along with a complete list of your current medications, as interactions may impact efficacy or alter the drug's action.
Primary Ingredients of Sartelbeta Plus 12.5mg/25mg/40mg Tablet ER
No text provided. Please provide the text you wish me to rewrite.
Uses of Sartelbeta Plus 12.5mg/25mg/40mg Tablet ER
Elevated arterial blood pressure
Major Benefits of Sartelbeta Plus 12.5mg/25mg/40mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Sartelbeta Plus 12.5mg/25mg/40mg Extended-Release Tablets. Ingest the tablets whole; avoid chewing, crushing, or breaking them. While consumption with or without food is acceptable, consistent daily timing is recommended for optimal results.
Common Side effects of Sartelbeta Plus 12.5mg/25mg/40mg Tablet ER:
- Nausea
- Diarrhea
- Upset stomach
- Headache
- Dizziness
- Cold extremities
- Numbness of extremity
- Increased blood lipid level
- Slow heart rate
- Decreased blood pressure
How to use Sartelbeta Plus 12.5mg/25mg/40mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Sartelbeta Plus 12.5mg/25mg/40mg Extended-Release Tablets. Ingest the tablets whole; avoid chewing, crushing, or breaking them. While this medication can be administered with or without food, consistent timing is recommended for optimal results.
How Sartelbeta Plus 12.5mg/25mg/40mg Tablet ER works:
Chlorthalidone, a diuretic agent, facilitates the excretion of excess fluid and select electrolytes via urinary output. Its long-term effects include vasodilation and enhanced circulation. Metoprolol Succinate, a beta-adrenergic blocking agent, acts selectively on cardiac tissue to reduce heart rate. Simultaneously, Telmisartan, an angiotensin receptor blocker, lowers blood pressure by inhibiting angiotensin II, promoting vasodilation.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Sartelbeta Plus 12.5mg/25mg/40mg ER tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Extended-release Sartelbeta Plus tablets (12.5mg/25mg/40mg) pose a confirmed risk to a developing fetus and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Sartelbeta Plus tablets (12.5mg/25mg/40mg) are likely unsafe for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Extended-release Sartelbeta Plus tablets (12.5mg/25mg/40mg) can cause drowsiness, blurred vision, and dizziness. Driving is inadvisable if these effects are experienced.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Sartelbeta Plus 12.5mg/25mg/40mg Extended-Release Tablets. Dosage modification may be necessary; physician consultation is advised. This medication is generally unsuitable for such patients.
LiverCAUTION
Patients with liver impairment should use Sartelbeta Plus 12.5mg/25mg/40mg Extended-Release Tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Sartelbeta Plus 12.5mg/25mg/40mg Extended-Release Tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Sartelbeta Plus 12.5mg/25mg/40mg Tablet ER :
Should you forget a Sartelbeta Plus 12.5mg/25mg/40mg Extended-Release tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Sartelbeta Plus 12.5mg/25mg/40mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |
